Clinical Trials at University of California, Los Angeles
As of August 2026, 85 paid clinical trials are recruiting at University of California, Los Angeles, located at CLARK UROLOGY CENTER 200 MEDICAL PLZ, SUITE #140, LOS ANGELES, CA 90095-0001, phone (310) 206-6766 in Los Angeles, California. Active studies at this site cover conditions such as Breast Cancer, Colorectal Cancer and Prostate Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Los Angeles
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Screening For Social Determinants Of Health In Routine Diabetes Care
Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial
89 clinical trials at University of California, Los Angeles
·Clear filters·Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies
A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety
Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer
Health And Response: Digital Markers for Outcomes in Perinatal Depression Treatment Study
Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial
A Pragmatic Trial of EAET for Veterans With Chronic Pain
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
Inter-Brain Synchrony in Schizophrenia
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
Multi-Center Clean Air Randomized Controlled Trial in COPD
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
RA-PRO PRAGMATIC TRIAL
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Deep Functional Phenotyping of the ALA Lung Health Cohort
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Nutrition for Precision Health, Powered by the All of Us
Automated Insulin for Management of Intrapartum Glycemia
Irritable Bowel Syndrome and Control Volunteers: Diet Challenge
ASSESS ALL ALS Study
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Prescription of Letrozole for Uterine Myoma
Social Facilitation of Emotion Regulation in Adolescence
Telerehabilitation In The Home After Stroke
Longitudinal Study of the Porphyrias
Common conditions studied in Los Angeles
- Breast Cancer (38 active studies)
- Colorectal Cancer (31 active studies)
- Prostate Cancer (27 active studies)
- Ovarian Cancer (23 active studies)
- Cancer (22 active studies)
- Heart Failure (21 active studies)
Leading research sponsors in Los Angeles
- University of California, Los Angeles
- University of Southern California
- Cedars-Sinai Medical Center
- Jonsson Comprehensive Cancer Center
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Los Angeles?
There are approximately 1,968 recruiting clinical trials in Los Angeles, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Los Angeles pay participants?
Most recruiting trials in Los Angeles compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Los Angeles?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Los Angeles?
The most common conditions under active study in Los Angeles include Breast Cancer (38), Colorectal Cancer (31), Prostate Cancer (27), Ovarian Cancer (23), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Los Angeles?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Los Angeles on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Los Angeles?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Los Angeles?
Recruiting research sites in Los Angeles include Cedars-Sinai Medical Center, Children's Hospital Los Angeles, University of California, Los Angeles, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Los Angeles right now?
The largest active categories in Los Angeles are Cancer & tumors (637), Neurology & pain (111), Cardiovascular (96). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of California, Los Angeles?
University of California, Los Angeles is located at CLARK UROLOGY CENTER 200 MEDICAL PLZ, SUITE #140, LOS ANGELES, CA 90095-0001. Use the Google Maps link in the intro above to get directions.
How do I contact University of California, Los Angeles?
You can reach University of California, Los Angeles by phone at (310) 206-6766. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.